Get started
Author

C. M. Schlotter

Observed names: C M Schlotter, C Schlotter, C. Schlotter, C.M. Schlotter, C. M. Schlotter, Claus M Schlotter, Claus M. Schlotter, Claus Martin Schlotter, Claus Schlotter, Schlotter, Claus M, Schlotter, Claus M., Schlotter, Claus Martin
Observed institutions: University of Bonn, University of Münster, University of Gdańsk, Klinikum Mittelbaden, University Hospital Münster, Klinikum Lüdenscheid, Universitäts Frauenklinik, Klinikum Fürth, St. Anna Hospital, Gdańsk Medical University, University of Tübingen
OpenAlex ID: A5110150882
Molecular targeted therapies for breast cancer treatment
2008 · Claus M Schlotter, Ulf Vogt, et al. · Breast Cancer Research · 86
PDF
C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer
2003 · Claus M Schlotter, Ulf Vogt, et al. · Breast Cancer Research · 71
PDF
Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease
2008 · M W Helms, D Kemming, et al. · British Journal of Cancer · 60
PDF
Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid
2004 · Ulf Vogt, Krzysztof Bielawski, et al. · Oncology Reports · 53
Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer1Published in conjunction with A Wisconsin Gathering Honoring Waclaw Szybalski on the occasion of his 75th year and 20 years of Editorship-in-Chief of Gene, 10–11 August, 1997, University of Wisconsin, Madison, WI, USA.1
1998 · Ulf Vogt, Krzysztof Bielawski, et al. · Gene · 44
Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: Double-differential polymerase chain reaction (ddPCR) for clinical diagnosis
1995 · B. Brandt, U. Vogt, et al. · Gene · 37
Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival
2017 · Claus M. Schlotter, Lothar Tietze, et al. · Hormone Molecular Biology and Clinical Investigation · 19
Relationship of c-myc and erbB oncogene family gene aberrations and other selected factors to ex vivo chemosensitivity of ovarian cancer in the modified ATP-chemosensitivity assay.
2000 · U Vogt, B Falkiewicz, et al. · Acta Biochimica Polonica · 11
PDF
Whole Genome Expression Analysis for Biologic Rational Pathway Modeling: Application in Cancer Prognosis and Therapy Prediction
2006 · D. Kemming, U. Vogt, et al. · Molecular Diagnosis & Therapy · 9
Neoadjuvant chemotherapy for breast cancer with weekly nab-paclitaxel followed by epirubicin and cyclophosphamide--results of a case series.
2014 · Antje Hahn, Claus M Schlotter, et al. · PubMed · 7
cDNA micro array profiling indicates selection of therapy resistant breast cancer cell clones in vivo
2005 · U. Vogt, N. Tidow, et al. · Journal of Clinical Oncology · 4
c-myc oncogene gene dosage, serum CEA and CA-15.3 antigen levels, and cellular DNA values in relation to ex vivo chemosensitivity of primary human breast cancer.
2000 · B Falkiewicz, C M Schlotter, et al. · Acta Biochimica Polonica · 4
PDF
Human Papillomavirus Genotypes in Cervical Cancer with Different Histological Features
2000 · Christiane Jakob, Claus Martin Schlotter, et al. · Gynecologic and Obstetric Investigation · 3
Bedeutung DNA-Bild-zytometrischer Parameter und etablierter Prognosefaktoren für krankheitsfreies Überleben (DFS) und Gesamtüberleben (OS) nodal-negativer Mammakarzinompatientinnen
2003 · C. M. Schlotter, U. Vogt, et al. · Zentralblatt für Gynäkologie · 2
Belastung der fetoplazentaren Einheit, der Muttermilch und Kuhmilch durch Radionuklide ein Jahr nach Tschernobyl
1989 · C. Schlotter, S. Vongehr, et al. · Geburtshilfe und Frauenheilkunde · 2
Beziehungen kardiotokographischer Parameter zum fetalen sowie materno-fetalen S�ure-Basen-Haushalt in der Er�ffnungs- und Austreibungsperiode
1977 · C. M. Schlotter, E. J�ger, et al. · Archives of Gynecology and Obstetrics · 2
Semi-quantitative gene expression profiling for therapy prediction in a breast cancer neoadjuvant therapy study applying docetaxel/epirubicin/cyclophosphamide
2007 · U. Vogt, D. Kemming, et al. · Journal of Clinical Oncology · 1
Interpretationsschwierigkeiten des Kardiotokogramms bei atrio-ventrikulärer Erregungsleitungsstörung des fetalen Herzens
1989 · C. Schlotter, G. Uhlhorn, et al. · Geburtshilfe und Frauenheilkunde · 1
Uterus septus mit Adenokarzinom der einen Korpushälfte
1984 · W. Beyer, G. Freißler, et al. · Geburtshilfe und Frauenheilkunde · 1
»Antepartale nichtinvasive Abklärung persistierender Rhythmusstörungen des fetalen Herzens«
1981 · C. Schlotter · Geburtshilfe und Frauenheilkunde · 1
Fetale Herzfrequenzmuster der Austreibungs- und Preßperiode — typische Muster, Häufigkeit, Azidoserisiko und Befundung: Beitrag zur praktischen Kardiotokographie
1979 · C. M. Schlotter, E. Jäger, et al. · Archives of Gynecology and Obstetrics · 1
Plasmahormonprofile bei Mutter und Kind
1977 · R. G�ser, W. Meierl, et al. · Archives of Gynecology and Obstetrics · 1
Symptomatologie der vorzeitigen L�sung der Placenta w�hrend Tokolyse
1977 · S. Kunz, C. M. Schlotter, et al. · Archives of Gynecology and Obstetrics · 1
Prediction of Metastasis in Node-Negative, Hormone Receptor Positive, Tamoxifen Adjuvant Treated Primary Breast Cancer Patients Using Ki-67 (IHC) and RT-PCR Based 14-Gene Prognostic Signature.
2009 · C. Schlotter, K. Wassmann, et al. · Cancer Research
Gene Expression Profiling for Therapy Prediction in a Breast Cancer Neoadjuvant Therapy Study Applying Docetaxel/Epirubicin/Cyclophosphamide.
2009 · D. Kemming, C. Schlotter, et al. · Cancer Research
Works count: 52
Citation count: 421
H-index: 9
I10-index: 8
Year
Topic
Type